Physician profile
Bethwel Raore
NPI 1215114475
$10,087.18
in general payments reported to CMS, 2019-2025
38 companies · $436 in 2025
The $436 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,053 · 2020: $2,201 · 2021: $2,302 · 2022: $559 · 2023: $1,526 · 2024: $2,010 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,172 · Consulting Fee: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,171.86 |
| Consulting Fee | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $2,442.74 | 2019-2023 | Alif, Vuepoint |
| Stryker Corporation | $2,361.52 | 2019-2024 | Spinejack, Capri Corpectomy Cage System |
| Abbott Laboratories | $1,724.14 | 2021-2023 | Proclaim, Eterna |
| Medtronic, INC. | $935.07 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Djo, LLC | $381.05 | 2021-2025 | Cmf |
| Boston Scientific Corporation | $251.60 | 2020-2023 | |
| Spineology INC. | $205.24 | 2020-2022 | |
| Si-Bone, INC. | $169.38 | 2019-2024 | |
| Osseus Fusion Systems, LLC | $150.00 | 2021 | |
| Depuy Synthes Sales INC. | $134.82 | 2019-2021 | |
| Globus Medical, INC. | $111.15 | 2019-2024 | Fortify |
| Encore Medical, Lp | $103.65 | 2023 | Djo Surgical |
| Orthofix Medical, INC. | $102.11 | 2020 | |
| Arteriocyte Medical Systems, INC. | $87.70 | 2024 | Magellan |
| Relievant Medsystems, INC. | $85.38 | 2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $74.84 | 2019 | |
| Surgalign Spine Technologies, INC. | $70.51 | 2021 | |
| Intrinsic Therapeutics | $69.74 | 2025 | Barricaid Acd (Annular Closure Device) |
| Theragen, INC. | $67.90 | 2021-2022 | |
| Aesculap Implant Systems, LLC | $60.00 | 2020 | |
| Arbor Pharmaceuticals, INC. | $59.55 | 2019-2021 | |
| Xtant Medical INC | $55.22 | 2023-2025 | |
| Kci USA, INC. | $45.00 | 2020 | |
| Kyocera Medical Technologies, INC. | $41.69 | 2022-2023 | |
| Augmedics INC. | $33.44 | 2021 | |
| Smith+Nephew, INC. | $29.82 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $24.60 | 2021 | |
| Davol INC. | $24.06 | 2020 | |
| Integra Lifesciences Corporation | $23.65 | 2019 | |
| Sanara Medtech INC. | $23.54 | 2024 | Celleraterx |
| Astrazeneca Pharmaceuticals Lp | $22.64 | 2023 | Andexxa |
| Spinal Simplicity, LLC | $20.59 | 2022 | |
| Pfizer INC. | $20.41 | 2021 | |
| Medtronic USA, INC. | $16.82 | 2019 | |
| Baxter Healthcare | $16.73 | 2024 | Floseal |
| Chiesi USA, INC. | $15.71 | 2019 | |
| Elutia, INC. | $13.91 | 2019 | |
| Synaptive Medical INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethwel Raore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.